Prominin 2 decreases cisplatin sensitivity in non-small cell lung cancer and is modulated by CTCC binding factor
By: Jiyang Tang, Dejun Shu, Zhimin Fang and Gaolan Yang
Authors
Jiyang Tang
Department of Thoracic Surgery, The Third Affiliated Hospital of ZunYi Medical University (The First People's Hospital of ZunYi), Zunyi, China
Dejun Shu
Department of Thoracic Surgery, The Third Affiliated Hospital of ZunYi Medical University (The First People's Hospital of ZunYi), Zunyi, China
Zhimin Fang
Department of Thoracic Surgery, The Third Affiliated Hospital of ZunYi Medical University (The First People's Hospital of ZunYi), Zunyi, China
Gaolan Yang
Department of Thoracic Surgery, The Third Affiliated Hospital of ZunYi Medical University (The First People's Hospital of ZunYi), Zunyi, China
Language: English
Page range: 325 - 336
Submitted on: Dec 21, 2022
Accepted on: Jun 21, 2023
Published on: Sep 4, 2023
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2023 Jiyang Tang, Dejun Shu, Zhimin Fang, Gaolan Yang, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution 4.0 License.